Hosted on MSN1y
SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-BankruptcyInvitae’s stock, which once soared above $50 ... approximately $90 million-100 million on an annualized basis. Price Action: NVTA shares are down 68.80% at $0.122 on the last check Monday.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback